IndraLab
Statements
reach
"Gefitinib induced substantial clinical responses and reduced tumour burden in ~ 10% of patients with chemotherapy-refractory non small cell lung cancers; however, the majority of these patients had EGFR mutations that constitutively activated the antiapoptotic protein AKT (Baselga, 2002; Fukuoka et al, 2003; Kris et al, 2003; Giaccone et al, 2004)."
reach
"Inhibition of EGFR activity using cetuximab partially abrogated the feedback activation of phosphorylated receptor tyrosine protein kinase erB-3 (p-HER3) and p-AKT serine/threonine kinase (AKT), as well as prevented reactivation of p-extracellular regulated kinase (ERK) conferred by AZD6244 treatment."
reach
"The in vivo assay demonstrated that EGFR and SOS1 promoted growth of nuclear p-AKT +, Bcl-2 + cells results in the resistance of hepatoma cells to ASPP2 and p53 complex induced apoptosis and that blocking nuclear translocation of EGFR dramatically improves and enhances the pro apoptotic function of ASPP2."
"down-regulation of GAK by small hairpin RNA has two pronounced effects on EGF receptor signaling: (i) the levels of receptor expression and tyrosine kinase activity go up by >50-fold; and (ii) the spectrum of downstream signaling is significantly changed. One very obvious result is a large increase in the levels of activated extracellular signal-regulated kinase 5 and Akt. "